These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 18372220

  • 1. Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats.
    Vernerová Z, Kramer HJ, Bäcker A, Cervenka L, Opocenský M, Husková Z, Vanourková Z, Eis V, Chábová VC, Tesar V, Malý J, Vanecková I.
    Vascul Pharmacol; 2008; 48(4-6):165-73. PubMed ID: 18372220
    [Abstract] [Full Text] [Related]

  • 2. Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats.
    Vanecková I, Kramer HJ, Bäcker A, Schejbalová S, Vernerová Z, Eis V, Opocenský M, Dvorák P, Cervenka L.
    Vascul Pharmacol; 2006 Sep; 45(3):163-70. PubMed ID: 16807127
    [Abstract] [Full Text] [Related]

  • 3. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Dvorák P, Kramer HJ, Bäcker A, Malý J, Kopkan L, Vanecková I, Vernerová Z, Opocenský M, Tesar V, Bader M, Ganten D, Janda J, Cervenka L.
    Kidney Blood Press Res; 2004 Sep; 27(4):248-58. PubMed ID: 15286437
    [Abstract] [Full Text] [Related]

  • 4. End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade.
    Vernerová Z, Kujal P, Kramer HJ, Bäcker A, Cervenka L, Vaneckova I.
    Physiol Res; 2009 Sep; 58 Suppl 2():S69-S78. PubMed ID: 20131938
    [Abstract] [Full Text] [Related]

  • 5. Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension.
    Opocenský M, Kramer HJ, Bäcker A, Vernerová Z, Eis V, Cervenka L, Certíková Chábová V, Tesar V, Vanecková I.
    Hypertension; 2006 Nov; 48(5):965-71. PubMed ID: 17015777
    [Abstract] [Full Text] [Related]

  • 6. Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats.
    Vanêcková I, Kramer HJ, Bäcker A, Vernerová Z, Opocensky M, Cervenka L.
    Hypertension; 2005 Oct; 46(4):969-74. PubMed ID: 16157796
    [Abstract] [Full Text] [Related]

  • 7. Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension.
    Vanourková Z, Kramer HJ, Erbanová M, Bäcker A, Cervenka L, Husková Z, Chábová VC, Tesar V, Dvorák P, Malý J, Vanecková I.
    Vascul Pharmacol; 2009 Oct; 50(5-6):194-9. PubMed ID: 19563737
    [Abstract] [Full Text] [Related]

  • 8. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
    Opocenský M, Dvorák P, Malý J, Kramer HJ, Bäcker A, Kopkan L, Vernerová Z, Tesar V, Zima T, Bader M, Ganten D, Janda J, Vanecková I.
    Physiol Res; 2004 Oct; 53(6):581-93. PubMed ID: 15588125
    [Abstract] [Full Text] [Related]

  • 9. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
    Husková Z, Kramer HJ, Vanourková Z, Cervenka L.
    J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
    [Abstract] [Full Text] [Related]

  • 10. Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.
    Husková Z, Kramer H, Vanourková Z, Thumová M, Malý J, Opocenský M, Skaroupková P, Kolský A, Vernerová Z, Cervenka L.
    Kidney Blood Press Res; 2007 Mar; 30(1):45-55. PubMed ID: 17259738
    [Abstract] [Full Text] [Related]

  • 11. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
    Vaněčková I, Kujal P, Husková Z, Vaňourková Z, Vernerová Z, Certíková Chábová V, Skaroupková P, Kramer HJ, Tesař V, Červenka L.
    Kidney Blood Press Res; 2012 Mar; 35(5):382-92. PubMed ID: 22487948
    [Abstract] [Full Text] [Related]

  • 12. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
    Chábová VC, Kramer HJ, Vanecková I, Vernerová Z, Eis V, Tesar V, Skaroupková P, Thumová M, Schejbalová S, Husková Z, Vanourková Z, Kolský A, Imig JD, Cervenka L.
    Vascul Pharmacol; 2007 Mar; 47(2-3):145-59. PubMed ID: 17604232
    [Abstract] [Full Text] [Related]

  • 13. Distinct effects of bosentan on NO-dependent vasodilation and calcium influx in heterozygous Ren-2 transgenic rats on high-salt diet.
    Vaněčková I, Hojná S, Kadlecová M, Kompanowska-Jezierska E, Zicha J.
    Physiol Res; 2019 Oct 25; 68(5):717-725. PubMed ID: 31424254
    [Abstract] [Full Text] [Related]

  • 14. Long-term prevention of hypertension and end-organ damage in Ren-2 transgenic rats is achieved only with persistent but not transient AT1 receptor blockade.
    Vanecková I, Kopkan L, Husková Z, Vanourková Z, Schejbalová S, Cervenka L, Kramer HJ.
    Kidney Blood Press Res; 2007 Oct 25; 30(1):38-44. PubMed ID: 17237618
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake.
    Vanecková I, Cahová M, Kramer HJ, Husková Z, Skaroupková P, Komers R, Bader M, Ganten D, Cervenka L.
    Kidney Blood Press Res; 2004 Oct 25; 27(4):203-10. PubMed ID: 15273422
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats.
    Hartner A, Porst M, Klanke B, Cordasic N, Veelken R, Hilgers KF.
    Nephrol Dial Transplant; 2006 Jul 25; 21(7):1778-85. PubMed ID: 16522658
    [Abstract] [Full Text] [Related]

  • 17. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
    Rakusan D, Kujal P, Kramer HJ, Husková Z, Vanourková Z, Vernerová Z, Mrázová I, Thumová M, Cervenka L, Vanecková I.
    Am J Physiol Renal Physiol; 2010 Oct 25; 299(4):F758-66. PubMed ID: 20668096
    [Abstract] [Full Text] [Related]

  • 18. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
    Čertíková Chábová V, Vernerová Z, Kujal P, Husková Z, Škaroupková P, Tesař V, Kramer HJ, Kompanowska-Jezierska E, Walkowska A, Sadowski J, Červenka L, Vaněčková I.
    Life Sci; 2014 Nov 24; 118(2):297-305. PubMed ID: 24373834
    [Abstract] [Full Text] [Related]

  • 19. Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade.
    Vaněčková I, Řezáčová L, Kuneš J, Zicha J.
    Life Sci; 2016 Aug 15; 159():127-134. PubMed ID: 26775568
    [Abstract] [Full Text] [Related]

  • 20. Endothelin A receptor blocker atrasentan lowers blood pressure by the reduction of nifedipine-sensitive calcium influx in Ren-2 transgenic rats fed a high-salt diet.
    Vaněčková I, Dobešová Z, Kuneš J, Vernerová Z, Zicha J.
    J Hypertens; 2015 Jan 15; 33(1):161-9. PubMed ID: 25255392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.